Nutrition
Volume 23, Issue 3 , Pages 254-260 , March 2007

Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination

Received 24 May 2006 ,Revised 9 January 2007

References 

  1. Carrat F, Valleron AJ. Le vaccine antigrippal (Revue bibliographique). Rev Mal Respir. 1994;11:239–255
  2. Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA. 2000;284:1655–1663
  3. Tamura S-I, Kurata T. Defense mechanisms against influenza virus infection in the respiratory tract mucosa. Jpn J Infect Dis. 2004;57:236–247
  4. Nichol KL, Lind A, Margolis KL, Murdoch M, McFadden R, Hauge M, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med. 1995;333(14):889–893
  5. Grotto I, Mandel Y, Green MS, Varsano N, Gdalevich M, Ashkenazi I, et al. Influenza vaccine efficacy in young, healthy adults. Clin Infect Dis. 1998;26:913–917
  6. Tamura S-I, Samegai Y, Kurata H, Nagamine T, Aizawa C, Kurata T. Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine. 1988;6:409–413
  7. Tamura S, Yamanaka A, Shimohara M, Tomita T, Komase K, Tsuda Y, et al. Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine. 1994;12:419–426
  8. Tamura S, Ito Y, Asanuma H, Hirabayashi S, Suzuki Y, Nagamine T, et al. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. J Immunol. 1992;22:477–481
  9. Matsuo K, Yoshikawa T, Asanuma H, Iwasaki T, Hagiwara Y, Chen Z, et al. Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin). Vaccine. 2000;18:2713–2722
  10. Mutsch M, Zhou W, Rhodes P, Bopp M, Chen RT, Linder T, et al. Use of the inactivated intranasal influenza vaccines and the risk of Bell’s palsy in Switzerland. New Eng J Med. 2004;350:896–903
  11. Schiffrin EJ, Rochat F, Lind-Amster H, Aeschlimann JM, Donnet-Hughes A. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci. 1995;78:491–497
  12. Arunachalam K, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr. 2000;54:263–267
  13. Gill HS, Rutherfurd KJ, Prasad J, Gopal PK. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br J Nutr. 2000;83:167–176
  14. Gill HS, Rutherfurd KJ, Cross ML, Gopal PK. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr. 2001;74:833–839
  15. Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr. 2001;73:444S–450S
  16. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res. 1992;32:141–144
  17. Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr. 1995;20:333–338
  18. Schiffrin EJ, Brassart D, Servin AL, Rochat F, Donnet-Hughes A. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am J Clin Nutr. 1997;66:515S–520S
  19. Nagao F, Nakayama M, Muto T, Okumura K. Effects of a fermented milk drink containing Lactobacillus casei strain shirota on the immune system in healthy human subjects. Biosci Biotechnol Biochem. 2000;64:2706–2708
  20. Hori T, Hiyosima J, Shida K, Yasui H. Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clin Diagn Lab Immunol. 2002;9:105–108
  21. Perdigón G, Alvarez S, Pesce de Ruiz Holgado A. Immunoadjuvant activity of oral Lactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections. J Dairy Sci. 1991;58:485–496
  22. de Vrese M, Rautengerg P, Laue C, Koopmans M, Herremans T, Schrezenmeir J. Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination. Eur J Nutr. 2005;44:406–413
  23. Martín R, Langa S, Reviriego C, Jiménez E, Marín ML, Xaus J, et al. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr. 2003;143:754–758
  24. Oddy WH, Sly PD, De Klerk NH, Landau LI, Kendall GE, Holt PG, et al. Breastfeeding and respiratory morbidity in infancy: a birth cohort study. Arch Dis Child. 2003;88:224–228
  25. Kovar MG, Serdula MK, Marks JS, Fraser DW. Review of the epidemiologic evidence for an association between infant feeding and infant health. Pediatrics. 1984;74(4 Pt 2):615–638
  26. Fallot ME, Boyd JL, Oski F. Breast-feeding reduces incidence of hospital admissions for infection in infants. Pediatrics. 1980;65:1121–1124
  27. Victora CG, Smith PG, Vaughan JP, Nobre LC, Lombardi C, Teixeira AM, et al. Evidence for protection by breast-feeding against infant deaths from infectious diseases in Brazil. Lancet. 1987;2:319–322
  28. Do Nascimento MBR, Issler H. Breastfeeding: making the difference in the development health and nutrition of term and preterm newborns. Rev Hosp Clin Fac Med Sao Paulo. 2003;58:49–60
  29. Xanthou M. Immune protection of human milk. Biol Neonate. 1998;74:121–133
  30. Martín R, Olivares M, Marín ML, Fernández L, Xaus J, Rodríguez JM. Probiotic potential of 3 lactobacilli strains isolated from breast milk. J Hum Lact. 2005;21:8–17
  31. Millot JL, Aymard M, Bardol A. Reduced efficiency of influenza vaccine in prevention of influenza-like illness in working adults: a 7 month prospective survey in EDF Gaz de France employees, in Rhône-Alpez, 1996–1997. Occup Med. 2002;52:281–292
  32. Liew FY, Russell SM, Brand CM. Induction and characterization of delayed-type hypersensitivity to influenza virus in mice. Eur J Immunol. 1979;9:783–790
  33. Monteiro JM, Harvey C, Trinchieri G. Role of interleukin-12 in primary influenza virus infection. J Immunol. 1998;72:4825–4831
  34. Cher DJ, Mosmann TR. Two types of murine helper T cell clone (Delayed-type hypersensitivity is mediated by Th1 clones). J Immunol. 1987;138:3688–3694
  35. Tamura S-I, Miyata K, Matsuo K, Asanuma H, Takahashi H, Nakajima K, et al. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein. J Immunol. 1996;156:3892–3900
  36. Olivares M, Diaz-Ropero MP, Gomez N, et al. Dietary deprivation of fermented foods causes a fall in innate immune response (Lactic acid bacteria can counteract the immunological effect of this deprivation). J Dairy Res. 2006;73:492–498
  37. Tamura S-I, Tanimoto T, Kurata T. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines. Jpn J Infect Dis. 2005;58:195–207
  38. Ogra PL, Mestecky J, Lamm ME, Strober W, Brenenstock J, McGhee JR. Mucosal immunology. London: Academic Press; 1999;
  39. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet. 2003;360:512–519
  40. Hessle C, Andersson B, Wold AE. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect Immun. 2000;68:3581–3586
  41. Haller D, Serrant P, Granato D, Schiffrin EJ, Blum S. Activation of human NK cells by Staphylococci and Lactobacilli requires cell contact-dependent costimulation by autologous monocytes. Clin Diagn Lab Immunol. 2002;9:649–657
  42. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 1994;84:4008–4027
  43. Medzhitov R, Janeway CR. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol. 1997;9:4–9
  44. Karlsson H, Hessle C, Rudin A. Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect Immun. 2002;70:6688–6696

 This study was supported by Puleva Biotech S.A. S. Sierra received a fellowship from the Fundación Universidad-Empresa (Universidad de Granada, Spain).

PII: S0899-9007(07)00011-1

doi: 10.1016/j.nut.2007.01.004

Nutrition
Volume 23, Issue 3 , Pages 254-260 , March 2007

Article Tools

* Image Usage & Resolution